Ioxaglic acid

{{Drugbox | IUPAC_name = 3-[(2-hydroxyethyl)carbamoyl]-2,4,6-triiodo-5-(2-{[2,4,6-triiodo-3-(methylcarbamoyl)-5-(N-methylacetamido)phenyl]formamido}acetamido)benzoic acid | image = Ioxaglic acid wiki str.png

| tradename = | Drugs.com = International Drug Names | pregnancy_AU = | pregnancy_US = | pregnancy_category = | legal_AU = | legal_CA = | legal_UK = | legal_US = | legal_status = | routes_of_administration =

| bioavailability = | protein_bound = | metabolism = | elimination_half-life = | excretion =

| CAS_number = | ATC_prefix = V08 | ATC_suffix = AB03 | PubChem = 3742 | DrugBank = | UNII_Ref =  ^Y | UNII = Z40X7EI2AF | KEGG = D01761 | ChEMBL = 1201291 | ChemSpiderID = 3611

| chemical_formula = | C=24 | H=21 | I=6 | N=5 | O=8 | molecular_weight = 1268.87906 g/mol | smiles = CC(=O)N(C)C1=C(C(=C(C(=C1I)C(=O)NCC(=O)NC2=C(C(=C(C(=C2I)C(=O)O)I)C(=O)NCCO)I)I)C(=O)NC)I | InChI = 1/C24H21I6N5O8/c1-7(37)35(3)20-17(29)10(21(39)31-2)13(25)11(18(20)30)23(41)33-6-8(38)34-19-15(27)9(22(40)32-4-5-36)14(26)12(16(19)28)24(42)43/h36H,4-6H2,1-3H3,(H,31,39)(H,32,40)(H,33,41)(H,34,38)(H,42,43) | InChIKey = TYYBFXNZMFNZJT-UHFFFAOYAE | StdInChI = 1S/C24H21I6N5O8/c1-7(37)35(3)20-17(29)10(21(39)31-2)13(25)11(18(20)30)23(41)33-6-8(38)34-19-15(27)9(22(40)32-4-5-36)14(26)12(16(19)28)24(42)43/h36H,4-6H2,1-3H3,(H,31,39)(H,32,40)(H,33,41)(H,34,38)(H,42,43) | StdInChIKey = TYYBFXNZMFNZJT-UHFFFAOYSA-N

}}

WikiDoc Resources for Ioxaglic acid
Articles
Most recent articles on Ioxaglic acid Most cited articles on Ioxaglic acid Review articles on Ioxaglic acid Articles on Ioxaglic acid in N Eng J Med, Lancet, BMJ
Media
Powerpoint slides on Ioxaglic acid Images of Ioxaglic acid Photos of Ioxaglic acid Podcasts & MP3s on Ioxaglic acid Videos on Ioxaglic acid
Evidence Based Medicine
Cochrane Collaboration on Ioxaglic acid Bandolier on Ioxaglic acid TRIP on Ioxaglic acid
Clinical Trials
Ongoing Trials on Ioxaglic acid at Clinical Trials.gov Trial results on Ioxaglic acid Clinical Trials on Ioxaglic acid at Google
Guidelines / Policies / Govt
US National Guidelines Clearinghouse on Ioxaglic acid NICE Guidance on Ioxaglic acid NHS PRODIGY Guidance FDA on Ioxaglic acid CDC on Ioxaglic acid
Books
Books on Ioxaglic acid
News
Ioxaglic acid in the news Be alerted to news on Ioxaglic acid News trends on Ioxaglic acid
Commentary
Blogs on Ioxaglic acid
Definitions
Definitions of Ioxaglic acid
Patient Resources / Community
Patient resources on Ioxaglic acid Discussion groups on Ioxaglic acid Patient Handouts on Ioxaglic acid Directions to Hospitals Treating Ioxaglic acid Risk calculators and risk factors for Ioxaglic acid
Healthcare Provider Resources
Symptoms of Ioxaglic acid Causes & Risk Factors for Ioxaglic acid Diagnostic studies for Ioxaglic acid Treatment of Ioxaglic acid
Continuing Medical Education (CME)
CME Programs on Ioxaglic acid
International
Ioxaglic acid en Espanol Ioxaglic acid en Francais
Business
Ioxaglic acid in the Marketplace Patents on Ioxaglic acid
Experimental / Informatics
List of terms related to Ioxaglic acid

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]

Overview

Ioxaglic acid (trade name Hexabrix) is an iodine containing molecule used as a low-osmolality contrast medium.

References

Template:Pharmacology-stub